3 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 3 |
| Phase 2 | 2 | Withdrawn 2 |
Follow Obstructive Sleep Apnea: new trials by email Literature Review of Obstructive Sleep Apnea trials Research Report on Obstructive Sleep Apnea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Exogenous Ketones on Sleep Apnea Ketone-IQ, Placebo - Obstructive Sleep Apnea, Sleep | Phase 1 / Phase 2 | Withdrawn | Johns Hopkins University | 2025-01-29 | 2026-09-21 | |
| Dex as Analgesic Adjuvant in OSA Patients Dexmedetomidine, Placebo - Obstructive Sleep Apnea | Phase 1 / Phase 2 | Withdrawn | Montefiore Medical Center | 2014-07-01 | 2018-08-03 | |
| Tongue Exercises and Reflux Therapy for Upper Airway Resistance Syndrome omeprazole, Tongue exercises - Obstructive Sleep Apnea, Upper Airway Resistance Syndrome | Phase 1 | Withdrawn | West Side ENT | 2006-08-01 | 2012-12-20 |
Sleep Apnea, Obstructive (3) · Apnea (1) · Fatigue (1) · Gastroesophageal Reflux (1) · Ketosis (1) · Motor Activity (1) · Sleep Apnea Syndromes (1)
Dyssomnias (3) · Nervous System Diseases (3) · Respiration Disorders (3) · Respiratory Tract Diseases (3) · Sleep Disorders, Intrinsic (3) · Sleep Wake Disorders (3) · Apnea (2) · Sleep Apnea Syndromes (2) · Acid-Base Imbalance (1) · Acidosis (1) · Behavior (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1)
Dexmedetomidine (1) · Omeprazole (1)
Johns Hopkins University (1) · Montefiore Medical Center (1) · West Side ENT (1)
United States (2)
Janet M Bennett, M.Ed,CCC-SLP (1) · Jonathan Jun, MD (1) · Omar Burschtin, MD (1) · Steven Y. Park, MD (1) · Tracey Straker, MD (1)